
Individuals with mild C. difficile colitis may have: Those with severe C. difficile colitis may have: Severe diarrhea also can lead to dehydration and disturbances in the electrolytes (minerals) in the body. Rarely, severe colitis can lead to life-threatening complications such as megacolon (markedly dilated colon), peritonitis (inflammation of the lining of the abdominal), and perforation of the colon. Clostridium difficile (C. difficile) is a bacterium that is related to the bacterium that cause tetanus andbotulism. The C. difficile bacterium has two forms, an active, infectious form that cannot survive in the environment for prolonged periods, and a nonactive, "noninfectious" form, called a spore, that can survive in the environment for prolonged periods. Although spores cannot cause infection directly, when they are ingested they transform into the active, infectious form. C. difficile spores are found frequently in: They can be found on: They even can be carried by pets. Thus, these environments are a ready source for infection with C. difficile. Antibiotic-associated (C. difficile) colitis is an infection of the colon caused by C. difficile that occurs primarily among individuals who have been using antibiotics. It is the most common infection acquired by patients while they are in the hospital. More than three million C. difficile infections occur in hospitals in the US each year. After a stay of only two days in a hospital, 10% of patients will develop infection with C. difficile. C. difficile also may be acquired outside of hospitals in the community. It is estimated that 20,000 infections with C. difficile occur in the community each year in the U.S.
Clostridium Difficile Colitis
(Antibiotic-Associated Colitis, C. difficileColitis, C. diff, C diff,)
Take the Tummy Trouble Digestive Quiz ![]()
Digestive Disease Myths Slideshow Pictures ![]()
Diverticulitis (Diverticulosis) Slideshow Pictures ![]()
Medical Editor: Jay Marks, M.D.
Symptoms of C. difficileColitis
What Are the Symptoms of C. difficileColitis?
What is Clostridium difficile(C. difficile)?
What is Clostridium difficile (C. difficile) colitis?
Clostridium difficile (C. difficile) is a bacterium
that is present naturally in the gut of around two-thirds of children
and 3% of adults. C. difficile does not cause any problems in healthy people. However,
some antibiotics that are used to treat other health conditions can
interfere with the balance of 'good' bacteria in the gut. When this
happens, C. difficile bacteria can multiply and produce toxins
(poisons), which cause illness such as diarrhoea and fever (see Symptoms
of C. difficile infection for more information). At this point, a
person is said to be infected with C. difficile. As C. difficile infections are usually caused by antibiotics, most
cases happen in a healthcare environment, such as a hospital or care
home. Older people are most at risk from infection, and most cases occur in
people aged over 65 (for more information, see Who
is most at risk from C. difficile infection?). Children under the
age of two are not usually affected. In recent years, the number of C. difficile infections has fallen
rapidly. In 2007-08, there were 55,498 cases reported across England. In
2008–09, there were 36,095 reported cases. This is a decrease of 35%. C. difficile bacteria spread very easily. Despite this, C. difficile
infections can usually be prevented by practising good hygiene in
healthcare environments, such as washing hands regularly and cleaning
surfaces using products containing bleach (see Prevention
of C. difficile infection for more information). You will only need treatment for a C. difficile infection if you have
symptoms. Sometimes, stopping the antibiotics is enough to clear the
infection. If symptoms are more severe, you may need to take medication
to clear the infection (see Treating
C. difficile infection for more information). Most people with a C. difficile infection make a full recovery.
However, in rare cases, the infection can be fatal. Last reviewed: 17/03/2010 Next review due: 17/03/2012 http://www.nhs.uk/conditions/Clostridium-difficile/Pages/Introduction.aspx
Clostridium
difficile
Who is affected?
How common is it?
Prevention
Outlook
In addition to the publication of meticillin-resistant Staphylococcus
aureus (MRSA) bacteraemia and Clostridium difficile infection (CDI) counts (monthly) and rates (annual) arising from the
mandatory surveillance scheme, the HPA produces quarterly
epidemiological commentaries. Aggregated over all English NHS acute Trusts, the commentaries
contain a description of the trends in the mandatory reports of these
healthcare-associated infections over a period of 9 quarters. The
commentaries also describe trends in other epidemiological factors such
as the age and sex profiles of patients with the infections and
differences in hospital demographics; for example patient provenance and
treatment specialities. In each commentary will be a special feature describing an in depth
analysis of some aspect of MRSA bacteraemia and/or C. difficile infection epidemiology. The commentary is produced as a single report combining both
organisms and is available as a PDF. This series began in December 2009. March 2010: Next publication date: 18th June 2010 (January-March 2007 to
January-March 2009 data). December 2009: http://www.hpa.org.uk/web/HPAweb&HPAwebStandard/HPAweb_C/1259151891722
Quarterly Epidemiological Commentaries on MRSA bacteraemia
and C. difficile infection
Current report:
Quarterly epidemiological commentary (PDF, 890 KB):
Trends in MRSA bacteraemia and C. difficile infection from
October 2007 to December 2009. Special features: a) Causes of MRSA
bacteraemia and b) Repeat episodes of Clostridium difficile.Previous report:
Quarterly epidemiological commentary (PDF, 317 KB):
Trends in MRSA bacteraemia and C. difficile infection from July
2007 to September 2009.
http://www.examiner.com/x-7707-Infectious-Disease-Examiner~y2010m3d25-C-difficile-infections-surpass-MRSA-in-community-hospitals
C. difficile infections surpass MRSA in community hospitals
The Duke team had looked at data from 28 hospitals in the network,
located in Georgia, North Carolina, South Carolina and Virginia. DICON
is a collaboration between Duke and 39 community hospitals that work
together on infection control issues.
What they found was during a 2 year period, the number of C.difficile
infections in the 28 participating hospitals was 25 percent higher than
the rate of infection due to Methicillin-Resistant Staphylococcus aureus
(MRSA).
According to Dr. Miller, “We found that MRSA infections have declined
steadily since 2005, but C. difficile infections have increased since
2007”.
What is C. difficile?
Clostridium difficile is a bacterium found throughout nature; soil,
water and the intestines of humans and various animals. It has been
isolated in the feces of 3% of healthy adults according to one study. It
is however more prevalent in hospitalized adults with colonization
rates of up to 30 percent seen.
It is implicated as a causative bacterium of antibiotic-associated
diarrhea (AAD) and pseudomembranous colitis (PMC). The problem is when
there is a decrease of normal intestinal flora typically due to the use
of antibiotics (the list of antibiotics is quite long). This allows the
C. difficile that is normally in check, to flourish and produce some
potent toxins that results in diarrhea or the potentially
life-threatening PMC.
C. difficile is laboratory diagnosed by detection of the toxin(s) in
feces. Vancomycin is the treatment of choice for C. difficile disease,
though relapses are common.
It is suspected by infection control experts that the common use of
alcohol hand cleansers which are effective against MRSA, are likely
ineffective against the spore-forming C. difficile, making it easier to
spread throughout a hospital environment.
Hospitals will likely use the same attention and vigor they used in
preventing MRSA and do the same for C. difficile.
Uusittu artikkeli/ An updated article:
What is Clostridium difficile (C.diff)? Clostridium difficile is a member of a large group of
bacteria, the clostridia, that grow in the absence of oxygen and are
able to form heat-resistant spores. C.diff is a very tough bug that lives in people's
intestines. It is common in young children and in people over the age of
75. When does it occur? It becomes a problem when a person's normal gut flora is
disturbed, for example during antibiotic treatment. As well as doing
its job to get rid of harmful bugs in the body, antibiotics also zap
away the "friendly bacteria". Why is C.diff such a problem? There are very few antibiotics that are effective
against C.diff and relapses are common after antibiotic treatment.
Without the aid of "friendly bacteria", the C.diff grows and produces
poison. How does it spread? C.diff is very clever in that it makes spores which are
very tough. They can last in the environment for years. Spores can be spread in the wind, but C.diff's most
efficient means of transport are the hands. It is very easy for the bug to get on the hands and once
the hands touch the mouth, it is then very easy for it to travel to the
gut. What is it resistant to? The bug can withstand heat. It can survive disinfectant
and it does not mind alcohol. What are the symptoms of C.diff? Symptoms of the bug include mild to severe diarrhoea,
blood-stained stools, fever and abdominal cramps. These symptoms are usually caused by an inflammation of
the lining of the large intestine. In rare cases, C.diff can cause
peritonitis, an infection of the lining in the abdomen, blood poisoning
and tears in the large intestine. In very rare cases, a C.diff infection can be fatal. The
risk of this is higher in elderly people and people who have other very
serious health conditions. Who is Professor Hugh Pennington? He chaired a Scottish Executive established expert group
following the E.coli O157 outbreak in central Scotland in 1996. http://news.bbc.co.uk/2/hi/uk_news/scotland/7710731.stm



